Market Tracker

10/31 11:34am ET
25.79
Real-Time Quote
 +0.13 / +0.51%
Today’s Change
19.92
Today|||52-Week Range
41.28
-33.22%
Year-to-Date

Today’s Trading

Previous close25.66
Today’s open26.28
Day’s range25.34 - 26.31
Volume295,646
Average volume (3 months)690,276
Market cap$1.6B
Dividend yield--
Data as of 11:19am ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-73.12%
Earnings growth (this year)-551.43%
Earnings growth (next 5 years)-0.75%
Revenue growth (last year)+23.14%
P/E ratioNM
Price/Sales3.26
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
AUXLAuxilium Pharmaceuti...+0.22+0.69%
RAREUltragenyx Pharmaceu...-0.02-0.04%
GWPHGW Pharmaceuticals P...+4.67+6.63%
THRXTheravance Inc+0.29+1.79%
Data as of 11:33am ET, 10/31/2014

Financials

Last reporting dateOctober 22, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$687.9M
Annual profit (last year)$15.5M
Net profit margin2.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Clive A. Meanwell
President, CFO, Treasurer &
Director
Glenn P. Sblendorio
Corporate headquarters
Parsippany, New Jersey

Forecasts